Clinical trials sponsored by Yunnan Cancer Hospital
3
Recruiting trials
5
Conditions studied
Phase breakdown
Not applicable 3
Conditions studied
| Condition | Trials |
|---|---|
| Clinical Complete Response Rate With Negative MRD | 1 |
| Colorectal cancer | 1 |
| Lung Cancer | 1 |
| NASH | 1 |
| Non-Alcoholic Fatty Liver Disease | 1 |
Recruiting trials led by Yunnan Cancer Hospital
- Application of DCE-MRI Based on 4D FreeBreathing in Predicting the Efficacy of Immune and Targeted Therapy in Lung Cancer
- Feasibility Study of Deep Learning-based MDixon Quant for Quantitative Assessment of Chemotherapy-induced Fatty Liver
- The Efficacy of Watch and Wait Strategy or Surgery After Neoadjuvant Immunotherapy for Locally Advanced Colorectal Cancer With dMMR/MSI-H Guided by MRD Dynamic Monitoring: A Single-center, Open-label, Prospective, Phase II Clinical Trial.
Common questions
How many trials is Yunnan Cancer Hospital recruiting for?
Yunnan Cancer Hospital is the lead sponsor of 3 recruiting trials.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.